In this module Shaji K Kumar MD Jeffrey P Sharman MD and Eunice S Wang MD review key studies in hematologic malignancies presented at ASCO 2024
- Provider:Clinical Care Options
- Activity Link: https://clinicaloptions.com/CE-CME/hematology/asco-2024-hematologic-malignancies/22600-46540
- Start Date: 2024-08-16 05:00:00
- End Date: 2024-08-16 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- Commercial Support: Source: GlaxoSmithKline - Amount: 8333.33 - Is Kind Support: False Source: Lilly (Any division) - Amount: 16666.67 - Is Kind Support: False Source: Novartis Corporation Pharmaceuticals - Amount: 13333.33 - Is Kind Support: False Source: Sanofi S.A. - Amount: 25000.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest